Coherent (COHR) Stock Soars to New Heights Following Jensen Huang’s Optical Netw...
Coherent (COHR) stock climbed 17.6% after Nvidia CEO spotlighted optical networking. Strong Q3 results, $2B Nvidia deal, and recor...
Fluence Energy (FLNC) Stock: Can 385% Annual Gains Continue After Recent Surge?
Fluence Energy (FLNC) stock surged 385% yearly to $22.91. Analysts set Hold rating with $19.47 target. Latest earnings and valuati...
Hewlett Packard Enterprise (HPE) Stock Pulls Back 8% Following Stellar 60% Surge...
HPE stock falls 8% after surging 60% in May. Goldman Sachs raises target to $79 following record Q2 earnings with $10.7B revenue a...
AXT (AXTI) Stock Plummets 16% Following CEO’s $22M Share Liquidation Near Peak P...
AXT (AXTI) stock plunged 16% after CEO Morris Young sold over $22M in shares. The price remains far above analyst targets despite...
SK Hynix (000660.KS) Stock Surges After Nvidia Taps It for Vera CPU Memory
SK Hynix stock rises as Nvidia CEO confirms partnership for Vera CPU DRAM. Jensen Huang warns memory shortages will continue for s...
Novo Nordisk (NVO) Stock: Can Amycretin Revive the Struggling Weight-Loss Giant?
Novo Nordisk (NVO) stock analysis: Amycretin phase 2 shows 14.6% weight loss, new Wegovy data at ADA 2026, and pipeline updates af...
Realty Income (O) Stock: Does Its Monthly Dividend Still Reign Supreme in 2026?
Realty Income (O) stock raises 2026 guidance to $4.41-$4.44 AFFO per share and increases investment target to $9.5B. Is this month...
NextEra Energy (NEE) Stock: Analysts Bullish on Growth, But Valuation Raises Que...
NextEra Energy (NEE) stock earns Moderate Buy rating after posting 8.2% EPS growth and record renewables backlog, but premium valu...
MercadoLibre (MELI) Stock: Why Major Investors Keep Accumulating Despite Earning...
MercadoLibre (MELI) stock analysis: institutional ownership at 87.62%, Q1 revenue up 49% to $8.85B, EPS misses at $8.23. Analyst t...
Pfizer (PFE) Stock Gains Ground on Once-Monthly Obesity Drug Breakthrough
Pfizer (PFE) stock climbed 1.36% on strong obesity drug data showing 15% weight loss, a $10.5B cancer deal, and vaccine trials ami...